Autor/in Becker, K Bokemeyer, Carsten Braumann, D 1 Bruweleit, Melanie 1 De Greve, J 1 De Wit, Maike 1 Harbeck, N 1 Hartmann, J T 1 Hoffmann, R 1 Hossfeld, Dieter 1 Janssens, J 1 Joosens, E 1 Köhne, C-H 1 Lang, I 1 Müller, L 1 Schilling, Georgia 1 Schütte, M 1 Thomssen, C 1 Vergauwe, P 1 Villena, C 1 alle zeigenListe einklappen
Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy). Schilling, Georgia Bruweleit, Melanie Harbeck, N Thomssen, C Becker, K Hoffmann, R Villena, C 2009 - Forschungsinformationssystem des UKE
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015. Köhne, C-H De Greve, J Hartmann, J T Lang, I Vergauwe, P Becker, K Braumann, D 2008 - Forschungsinformationssystem des UKE